Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

PHASE2UnknownINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2022

Conditions
Ulcerative Colitis
Interventions
DRUG

AMT-101 (oral)

AMT 101 is orally administered biological therapeutic taken once daily

OTHER

Placebo (oral)

Orally administered placebo comparator taken once daily

Trial Locations (59)

1033

Clinexpert Kft., Budapest

1083

Semmelweis Egyetem Altalanos Orvostudomanyi Kar, Budapest

1336

MHAT Lyulin EAD, Sofia

2600

Javorszky Odon Korhaz, Gasztroenterologiai Osztaly, Vác

2700

MHAT Blagoevgrad AD, Blagoevgrad

4031

Clarunis Bauchzentrum, Basel

6725

Szegedi Tudomanyegyetem, Szeged

7700

Mohacsi Korhaz, Mohács

7747

Universitätsklinikum Jena Klinik fuer Innere Medizin IV, Jena

10003

Limited Liability Company Medibor, Zhytomyr

20815

Chevy Chase Clinical Research, Chevy Chase

21029

Vinnytsya City Clinical Hospital No 1, Vinnytsia

21339

Staedtisches Klinikum Lueneburg, Lüneburg

24105

University Hospital Schleswig-Holstein, Kiel

25006

"Medical and Diagnostic Centre of Private Enterprise of Private Manufacturing Company Acinus", Kropyvnytskyi

27834

Carolina Research, Greenville

28200

Nowe Zdrowie CK Kieltucki I Wspólnicy sp.j., Staszów

30519

Gwinnett Research Institute, LLC, Buford

32127

Advanced Medical Research Center, Port Orange

32803

AdventHealth - Florida Hospital, Orlando

35326

Centrum Medyczne Medyk, Rzeszów

37909

GIA Clinical Trials, LLC, Knoxville

38004

Washington Gastroenterology, Bellevue

38138

Gastro One, Germantown

42270

CHU Saint-Etienne - Hospital Nord Gastroenteroloy, Saint-Priest-en-Jarez

44190

Indywidualna Praktyka Lekarska Maciej Zymła, Knurów

48197

Huron Gastroenterology Associates, Ypsilanti

61019

Regional Hospital of War Veterans, Kharkiv

69076

Medical Center of Limited Liability Co, Zaporizhzhia

72076

Universitätsklinikum Tübingen, Tübingen

75701

Tyler Research Institute, LLC, Tyler

79010

Lviv Regional Clinical Hospital, Lviv

79424

Caprock Gastro Research, Lubbock

81756

Endoskopia Sp. z o.o., Sopot

84112

University of Utah Hospitals and Clinics, Salt Lake City

85079

Vitamed Gałaj i Cichomski S.J., Bydgoszcz

87100

Gastromed Kopon, Zmudziski I Wspolnicy Sp.j., Torun

88009

Uzhgorod National University, Uzhhorod

92377

Inland Empire Clinical Trials, LLC, Rialto

95054

Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska S.J., Ksawerów

98405

Washington Gastroenterology, PLLC, Tacoma

150000

Medical Diagnostics Center, LLC, Yaroslavl

210037

Vitebsk Regional Clinical Hospital, Vitebsk

630007

Novosibirsk GastroCenter LLC, Novosibirsk

37212-1375

Vanderbilt University Medical Center, Nashville

V6Z2K5

GI Research Institute, Vancouver

N6A5W9

London Health Sciences Centre - Victoria Hospital, London

L4L4Y7

Toronto Digestive Disease Associates Specialty Research, Vaughan

0112

Arensia Exploratory Medicine GmbH, Tbilisi

MD-2025

"Clinical Republican Hospital Timofei Mosneaga, ARENSIA E.M.", Chisinau

86-300

Centrum Medyczne CLW-MED, Grudziądz

54-144

Vistamed & Vertigo Sp. z o.o, Wroclaw

00728

WIP Warsaw IBD Point Profesor Kierkus, Warsaw

03-580

Nzoz Vivamed, Warsaw

89-600

Centrum Medyczne LUKAMED Joanna Luka-Wendrowska, Chojnice

01135

Medical center limited liability Harmoniya Krasy, Kyiv

02091

Medical Center Ok!Clinic+ International Institute, Kyiv

04073

CI of Kyiv RC Regional Clinical Hospital No 2, Kyiv

S75 2EP

Barnsley Hospital NHS Foundation Trust, Barnsley

Sponsors
All Listed Sponsors
lead

Applied Molecular Transport

INDUSTRY

NCT04583358 - Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD) | Biotech Hunter | Biotech Hunter